IL37 and systemic lupus erythematosus: Our previous study also showed that IL-37 can inhibit PBMCs of systemic lupus erythematosus (SLE) patient to produce pro-inflammatory cytokines, and its expressions are positively associated with SLE renal disease activity [34].